Sabby Management’s Sonnet BioTherapeutics SONN Stock Holding History

Sabby Management’s Portfolio SONN Stock Details SONN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell
2024 Q2	$223K	Buy
2023 Q3	–	Sell
2023 Q2	$1.61M	Buy
2023 Q1	$438K	Buy